US › Healthcare

Sensus Healthcare Inc (SRTS)

US · Healthcare · Medical Devices

$3.12+1.63%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$2.3M

Revenue YoY

-68.7%

Net profit

$-8.7M

EPS

$-0.18

EPS estimate

$-0.11

Net margin

-382.1%

EPS came in at -0.18 against a street estimate of -0.11 — a miss of 63.6%.

Key statistics

Market cap

$50.7M

Forward P/E

21.4

P/B

1.36

Book value

$2.24

EPS (TTM)

$-0.94

52-week high

$5.49

52-week low

$2.66

50-day MA

$3.10

200-day MA

$3.73

Beta

1.14

Analyst view

Analysts rate Sensus Healthcare Inc a buy (5 buy, 0 hold, 0 sell out of 5) with an average price target of $5.38.

Shareholding

Insiders

18.67%

Institutions

26.79%

Largest institutional holders

Fund	Stake
Pacific Ridge Capital Partners, LLC	4.80%
Vanguard Capital Management, LLC	3.94%
Dimensional Fund Advisors, Inc.	1.92%
Divisadero Street Capital Management, LP	1.74%
Renaissance Technologies Corp	1.53%
UBS Group AG	1.05%
Geode Capital Management, LLC	1.01%
Meros Investment Management, LP	0.93%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Sensus Healthcare Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.